J. Erfán
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 4
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
- Lung Cancer Research Studies 1
-
- Head and Neck Cancer Studies 3
- Co-authors
- Ricard Mesı́a (3 shared papers)Éva Remenár (3 shared papers)Sylvie Rottey (3 shared papers)Ricardo Hitt (3 shared papers)Andrzej Kawecki (2 shared papers)Marco Benasso (2 shared papers)JB Vermorken (1 shared paper)Christopher Stroh (1 shared paper)
In The Last Decade
J. Erfán
9 papers receiving 352 citations
Peers
Comparison fields: 5 of 34
- Otorhinolaryngology 144
- Oncology 165
- Immunology and Allergy 21
- Pulmonary and Respiratory Medicine 96
- Cancer Research 31
Countries citing papers authored by J. Erfán
This map shows the geographic impact of J. Erfán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Erfán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Erfán more than expected).
Fields of papers citing papers by J. Erfán
This network shows the impact of papers produced by J. Erfán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Erfán. The network helps show where J. Erfán may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Erfán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 181 | |
| 2 | 2014 | 77 | |
| 3 | 2014 | 48 | |
| 4 | 2007 | 18 | |
| 5 | 2006 | 17 | |
| 6 | 2011 | 9 | |
| 7 | 2017 | 2 | |
| 8 | 1348P Overall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: results from two phase II studies. | 2017 | 2 |
| 9 | [Quality assurance, audit and quality control of radiotherapy at radiology departments in Hungary]. | 1995 | 1 |
About J. Erfán
J. Erfán is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 355 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Treatment and Pharmacology (2 papers), HER2/EGFR in Cancer Research (2 papers), Advanced Radiotherapy Techniques (1 paper), Breast Cancer Treatment Studies (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Otorhinolaryngology (144 citations), Oncology (165 citations), Immunology and Allergy (21 citations), Pulmonary and Respiratory Medicine (96 citations) and Cancer Research (31 citations). J. Erfán has collaborated with scholars based in Hungary, Belgium and Germany. Frequent co-authors include Ricard Mesı́a, Éva Remenár, Sylvie Rottey, Ricardo Hitt, Andrzej Kawecki, Marco Benasso, JB Vermorken, Christopher Stroh, Stefanie Senger and Lisa Licitra. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Investigational New Drugs, European Journal of Cancer Supplements and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.